News
Drug regulator tells Johnson & Johnson to Pay Rs 74.5 lakh to patient with ‘faulty’ hip implant
Johnson & Johnson had marketed the ASR (articular surface replacement) implants in India through its subsidiary DePuy between 2004 and 2010. …
Read more
News
Dr Reddy's gains 2% as USFDA completes audit of US plant with zero Form.483 observations
Share price of Dr Reddy's Laboratories gained more than 2 percent intraday Friday after company received zero observations for its plant. …
Read more
News
USFDA lifts warning on Dr Reddy's Duvvada unit, relief after Bachupally formulation Unit observations
Duvvada resolution is expected to give a huge fillip to the company, as around 20% of its future ANDA (abbreviated new drug applications) filings w…
Read more
News
Update about ICH guidelines on Continuous manufacturing of Pharmaceutical products | Pharma Udyog
Update about ICH guidelines on Continuous Manufacturing In June 2018 already, the International Council for Harmonisation (ICH) announced the c…
Read more
News
Data integrity : Compliance - GMP and FDA Requirements | 21 CFR Part 11 | Pharma Udyog
Data integrity is an old concept made essential in today’s digital age, and means data that is accurate, complete, and repeatable, which in turn en…
Read more
Sun Pharma
Sun Pharma Biggest recall | The administration of a glass particulate
Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of …
Read more
News
Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets | Pharma News | Pharma Udyog
Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwid…
Read more
Social Plugin